17 Jan 2022 Bionest Novartis and UK NHS Collaborate for Targeted Access to Levqio Novartis is teaming up with the NHS to make the PCSK9 inhibitor Leqvio available for UK heart patients who struggle to control their LDL cholesterol with existing drugs.